Neurology

GLP-1 receptor agonists and SGLT2 inhibitors are associated with a lower risk of dementia, suggesting these drugs may have a neuroprotective effect.

The DISTAL and ESCAPE MeVO trials were neutral for thrombectomy in distal vessel occlusions — were the patients who would benefit simply not enrolled and what will the investigators do going forward?

Dapagliflozin after TAVI? Semaglutide for claudication? Two trials designed to be positive should not warrant new indications for these drugs writes John Mandrola, MD.

A 55-year-old man with obesity, a 1-year history of snoring, witnessed apneas and gasping, and daytime sleepiness is experiencing poor sleep. How would you manage this patient?

Pediatric dermatologists love what they do but struggle to attract others to their subspecialty.